130 related articles for article (PubMed ID: 9198249)
1. Thrombolytic therapy.
Collen D
Thromb Haemost; 1997 Jul; 78(1):742-6. PubMed ID: 9198249
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic agents: mechanisms of activity and pharmacology.
Lijnen HR; Collen D
Thromb Haemost; 1995 Jul; 74(1):387-90. PubMed ID: 8578491
[TBL] [Abstract][Full Text] [Related]
3. Newer thrombolytic drugs for acute myocardial infarction.
Reddy DS
Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy: then and now.
Cole PL
Heart Lung; 1991 Sep; 20(5 Pt 2):542-51. PubMed ID: 1910023
[TBL] [Abstract][Full Text] [Related]
5. New thrombolytic agents and strategies.
Collen D; Lijnen HR
Baillieres Clin Haematol; 1995 Jun; 8(2):425-35. PubMed ID: 7549072
[TBL] [Abstract][Full Text] [Related]
6. Development of thrombolytic agents.
Lijnen HR; Collen D
Biotechnol Adv; 1993; 11(1):115-30. PubMed ID: 14544810
[TBL] [Abstract][Full Text] [Related]
7. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy for myocardial infarction.
Guerci AD
Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action and thrombolytic potential of staphylokinase.
Lijnen HR
Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
[TBL] [Abstract][Full Text] [Related]
10. Designing thrombolytic agents: focus on safety and efficacy.
Collen D
Am J Cardiol; 1992 Jan; 69(2):71A-81A. PubMed ID: 1729881
[TBL] [Abstract][Full Text] [Related]
11. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
Kobusiak-Prokopowicz M; Mysiak A
Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
[TBL] [Abstract][Full Text] [Related]
12. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
13. The tissue-type plasminogen activator story.
Collen D; Lijnen HR
Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
[TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic treatment of acute myocardial infarct. 1].
Soares-Costa JT; Soares-Costa TJ; Gabriel HM
Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
[TBL] [Abstract][Full Text] [Related]
15. Design of novel thrombolytic agents via domain modifications.
Erickson LA; Marotti KR
Toxicol Pathol; 1990; 18(4 Pt 1):597-602. PubMed ID: 2128661
[TBL] [Abstract][Full Text] [Related]
16. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
[TBL] [Abstract][Full Text] [Related]
18. [Staphylokinase--a specific plasminogen activator].
Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis in newborns and infants.
Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
[TBL] [Abstract][Full Text] [Related]
20. Novel thrombolytic agents.
Verstraete M; Lijnen HR
Cardiovasc Drugs Ther; 1994 Dec; 8(6):801-11. PubMed ID: 7742258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
